文献速递头痛与眩晕

基于电子日记比较围月经期与非围月经期偏头痛发作

Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary.
PubMed 文献 · Neurology · 2021-09-07

研究纳入500名偏头痛女性,通过头痛电子日记比较围月经期与非围月经期发作特征。围月经期发作持续更长(20.0 vs 16.1小时),复发风险更高(OR 2.4),曲普坦使用增加(OR 1.2),头痛强度更高(OR 1.4),畏光畏声更明显,先兆更少。月经相关偏头痛(MRM)和使用激素避孕者差异更显著。

要点

  • 围月经期偏头痛发作持续时间更长且复发风险更高。
  • 围月经期发作曲普坦使用增加,需警惕药物过度使用。
  • MRM患者围月经期发作特征差异更为显著。

核心结论

  • 围月经期偏头痛发作持续时间更长,与更高复发风险和曲普坦使用增加相关。
  • 这可能增加药物过度使用风险,强调需要开发女性特异性预防治疗。

研究设计与样本

  • 邀请偏头痛女性完成头痛电子日记,比较围月经期与非围月经期发作特征。
  • 500名参与者完成至少1个月电子日记,其中396名完成≥3个连续月经周期。
  • 使用混合效应模型解释患者内多次发作。

主要发现

  • 围月经期发作(n=998)相比非围月经期发作(n=4097)持续时间更长(20.0 vs 16.1小时,95%CI 0.2-0.4)。
  • 围月经期发作复发风险更高(OR 2.4 [2.0-2.9]),曲普坦使用增加(OR 1.2 [1.1-1.4])。
  • 围月经期发作头痛强度更高(OR 1.4 [1.2-1.7]),疼痛应对更差(均差-0.2 [-0.3至-0.1])。
  • 围月经期发作畏光更明显(OR 1.3 [1.2-1.4]),畏声更明显(OR 1.2 [1.1-1.4]),先兆更少(OR 0.8 [0.6-1.0])。
  • 396名完成≥3个连续月经周期者中56%(221/396)符合MRM标准,MRM患者和非MRM患者PMS患病率无差异(11% vs 15%)。

临床怎么用

  • 对围月经期偏头痛发作应关注更长持续时间和更高复发风险。
  • 围月经期曲普坦使用增加,需监测药物过度使用风险。
  • 考虑为女性开发特异性预防治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Endogenous and exogenous female sex hormones are considered important contributors to migraine pathophysiology. Previous studies have cautiously suggested that perimenstrual migraine attacks have a longer duration and are associated with higher disability compared to nonperimenstrual attacks, but they showed conflicting results on acute therapy efficacy, pain intensity, and associated symptoms. We compared perimenstrual and nonperimenstrual migraine attack characteristics and assessed premenstrual syndrome (PMS) in women with migraine. METHODS: Women with migraine were invited to complete a headache e-diary. Characteristics of perimenstrual attacks and nonperimenstrual attacks were compared. The primary outcome was attack duration. Secondary outcomes were headache intensity, accompanying symptoms, acute medication intake, and pain coping. Mixed effects models were used to account for multiple attacks within patients. PMS was assessed in patients without hormonal contraceptives. Subgroup analyses were performed for women with menstrually related migraine (MRM) and nonmenstrually related migraine (non-MRM) and women with a natural menstrual cycle and women using hormonal contraceptives. RESULTS: A representative group of 500 participants completed the e-diary for at least 1 month. Perimenstrual migraine attacks (n = 998) compared with nonperimenstrual attacks (n = 4097) were associated with longer duration (20.0 vs 16.1 hours, 95% confidence interval 0.2-0.4), higher recurrence risk (odds ratio [OR] 2.4 [2.0-2.9]), increased triptan intake (OR 1.2 [1.1-1.4]), higher headache intensity (OR 1.4 [1.2-1.7]), less pain coping (mean difference -0.2 [-0.3 to -0.1]), more pronounced photophobia (OR 1.3 [1.2-1.4]) and phonophobia (OR 1.2 [1.1-1.4]), and less aura (OR 0.8 [0.6-1.0]). In total, 396/500 women completed the diary for ≥3 consecutive menstrual cycles, of whom 56% (221/396) fulfilled MRM criteria. Differences in attack characteristics became more pronounced when focusing on women with MRM and women using hormonal contraceptives. Prevalence of PMS was not different for women with MRM compared to non-MRM (11% vs 15%). DISCUSSION: The longer duration of perimenstrual migraine attacks in women (with MRM) is associated with higher recurrence risk and increased triptan use. This may increase the risk of medication overuse and emphasizes the need to develop female-specific prophylactic treatment.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. van Casteren DS, Verhagen IE, van der Arend BWH, et al. Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary. Neurology. 2021. PMID: 34493613. doi:10.1212/WNL.0000000000012723

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。